Evaluating the Use of Peppermint Oil for Postpartum Women With Urinary Retention
| Registry | NCT05259800 |
|---|---|
| Status | Terminated - Difficulty enrolling patients |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 17 (Actual) |
| Sponsor | TriHealth Inc. (Other) |
| Conditions | Urinary Retention |
| Interventions | Peppermint oil vapors, Mineral Oil (Other) |
| Dates | start 2021-10-05, primary completion 2025-04-01, completion 2025-04-01, first posted 2022-03-02, last updated 2025-08-29 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Urinary Retention All trials of Peppermint oil vapors All trials of Mineral Oil
A randomized controlled study will be conducted, with two arms. Postpartum women experiencing urinary retention will be randomized into one of the two following arms:
* Arm 1: Subjects will be exposed to vapor of peppermint oil
* Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.
The purpose of the study is to determine if the use of peppermint oil among postpartum women experiencing urinary retention will increase spontaneous urination and decrease the need for catheterization. A randomized controlled study will be conducted, with two arms. Subjects will be randomized into one of the two following arms:
* Arm 1: Subjects will be exposed to vapor of peppermint oil
* Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Peppermint Oil | Experimental | Other: Peppermint oil vapors | Subjects will be exposed to vapor of peppermint oil |
| Placebo | Placebo comparator | Other: Mineral Oil | Subjects will be exposed to vapor of placebo (mineral oil) |
Sex: Female, ages: 18 Years to any, accepts healthy volunteers
Inclusion Criteria: * 1\. 18 years old or older 2. English speaking 3. Admitted to Bethesda North Mom Baby Unit 4. Postpartum 5. Experiencing urinary retention - defined as meeting at least one of the following criteria: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void 6. Bladder scan showing bladder containing 400mL or more urine Exclusion Criteria: 1. Allergy to peppermint 2. Asthma 3. Active herpes lesions 4. Seizure disorder 5. Not able to void in toilet (ex: requiring use of bed pan to void)
| Milestone | Peppermint Oil | Placebo |
|---|---|---|
| Started | 10 | 7 |
| Completed | 10 | 7 |
| Not completed | 0 | 0 |
Time frame: from enrollment until end of follow-up, up to 2 days
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|---|---|---|
| Peppermint Oil | 0/10 (0.0%) | 0/10 (0.0%) | 0/10 (0.0%) |
| Placebo | 0/7 (0.0%) | 0/7 (0.0%) | 0/7 (0.0%) |
| Facility | City | Country | Status |
|---|---|---|---|
| Bethesda North Hospital | Cincinnati, Ohio | United States |